secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagonist Therapeutics, Inc (PTGX)
CIK:        0001377121
Form:       8-K
Filed at:   2026-06-18T20:30:53+00:00
Accession:  0001104659-26-075777
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagonist Therapeutics stockholders approve 2026 equity plan, adding 650K new shares
--------------------------------------------------------------------------------

- Stockholders approved adoption of 2026 Equity Incentive Plan, replacing 2016 plan; adds 650,000 new shares plus carryover from prior plan and returning shares.
- Dinesh Patel and Lewis Williams re-elected as Class I directors with 48.7M and 45.4M votes for, respectively.
- Say-on-pay passed: 53.4M for, 3.2M against; Ernst & Young ratified as independent auditor (59.4M for, 28K against).
- Plan approval received 47.7M for, 8.8M against; broker non-votes of 2.8M on all proposals except auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1377121/000110465926075777/0001104659-26-075777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1377121/000110465926075777/tm2618251d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-075777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer